243 related articles for article (PubMed ID: 22789878)
1. Microparticles in cardiovascular disease pathophysiology and outcomes.
Viera AJ; Mooberry M; Key NS
J Am Soc Hypertens; 2012; 6(4):243-52. PubMed ID: 22789878
[TBL] [Abstract][Full Text] [Related]
2. Microparticles and arterial disease.
Blann A; Shantsila E; Shantsila A
Semin Thromb Hemost; 2009 Jul; 35(5):488-96. PubMed ID: 19739039
[TBL] [Abstract][Full Text] [Related]
3. Microparticles, vascular function and hypertension.
Boulanger CM
Curr Opin Nephrol Hypertens; 2010 Mar; 19(2):177-80. PubMed ID: 20051854
[TBL] [Abstract][Full Text] [Related]
4. Microparticles: targets and tools in cardiovascular disease.
Martinez MC; Tual-Chalot S; Leonetti D; Andriantsitohaina R
Trends Pharmacol Sci; 2011 Nov; 32(11):659-65. PubMed ID: 21794929
[TBL] [Abstract][Full Text] [Related]
5. Involvement of microparticles in diabetic vascular complications.
Tsimerman G; Roguin A; Bachar A; Melamed E; Brenner B; Aharon A
Thromb Haemost; 2011 Aug; 106(2):310-21. PubMed ID: 21713319
[TBL] [Abstract][Full Text] [Related]
6. Microparticles: key protagonists in cardiovascular disorders.
Amabile N; Rautou PE; Tedgui A; Boulanger CM
Semin Thromb Hemost; 2010 Nov; 36(8):907-16. PubMed ID: 21069633
[TBL] [Abstract][Full Text] [Related]
7. Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: Relation to cardiovascular complications.
Tantawy AA; Adly AA; Ismail EA; Habeeb NM; Farouk A
Platelets; 2013; 24(8):605-14. PubMed ID: 23249216
[TBL] [Abstract][Full Text] [Related]
8. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease.
Nozaki T; Sugiyama S; Koga H; Sugamura K; Ohba K; Matsuzawa Y; Sumida H; Matsui K; Jinnouchi H; Ogawa H
J Am Coll Cardiol; 2009 Aug; 54(7):601-8. PubMed ID: 19660689
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of circulating endothelial microparticles for cardiovascular mortality in end-stage renal failure: a pilot study.
Amabile N; Guérin AP; Tedgui A; Boulanger CM; London GM
Nephrol Dial Transplant; 2012 May; 27(5):1873-80. PubMed ID: 22036944
[TBL] [Abstract][Full Text] [Related]
10. Increased circulating microparticles in streptozotocin-induced diabetes propagate inflammation contributing to microvascular dysfunction.
Feng Q; Stork CJ; Xu S; Yuan D; Xia X; LaPenna KB; Guo G; Sun H; Xu LC; Siedlecki CA; Brundage KM; Sheaffer N; Schell TD; He P
J Physiol; 2019 Feb; 597(3):781-798. PubMed ID: 30548258
[TBL] [Abstract][Full Text] [Related]
11. Microparticles as new markers of cardiovascular risk in diabetes and beyond.
Santilli F; Marchisio M; Lanuti P; Boccatonda A; Miscia S; Davì G
Thromb Haemost; 2016 Aug; 116(2):220-34. PubMed ID: 27173919
[TBL] [Abstract][Full Text] [Related]
12. Cell-derived microparticles: a new challenge in neuroscience.
Doeuvre L; Plawinski L; Toti F; Anglés-Cano E
J Neurochem; 2009 Jul; 110(2):457-68. PubMed ID: 19457085
[TBL] [Abstract][Full Text] [Related]
13. Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses.
Morel O; Morel N; Freyssinet JM; Toti F
Platelets; 2008 Feb; 19(1):9-23. PubMed ID: 18231934
[TBL] [Abstract][Full Text] [Related]
14. The involvement of circulating microparticles in inflammation, coagulation and cardiovascular diseases.
Puddu P; Puddu GM; Cravero E; Muscari S; Muscari A
Can J Cardiol; 2010 Apr; 26(4):140-5. PubMed ID: 20386775
[TBL] [Abstract][Full Text] [Related]
15. A heparin-based method for flow cytometric analysis of microparticles directly from platelet-poor plasma in calcium containing buffer.
Iversen LV; Ostergaard O; Nielsen CT; Jacobsen S; Heegaard NH
J Immunol Methods; 2013 Feb; 388(1-2):49-59. PubMed ID: 23246793
[TBL] [Abstract][Full Text] [Related]
16. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism.
Campello E; Spiezia L; Radu CM; Bulato C; Castelli M; Gavasso S; Simioni P
Thromb Res; 2011 May; 127(5):473-7. PubMed ID: 21256535
[TBL] [Abstract][Full Text] [Related]
17. Microparticles and vascular dysfunction in obstructive sleep apnoea.
Trzepizur W; Martinez MC; Priou P; Andriantsitohaina R; Gagnadoux F
Eur Respir J; 2014 Jul; 44(1):207-16. PubMed ID: 24627532
[TBL] [Abstract][Full Text] [Related]
18. Chronic renal failure is accompanied by endothelial activation and a large increase in microparticle numbers with reduced procoagulant capacity.
Trappenburg MC; van Schilfgaarde M; Frerichs FC; Spronk HM; ten Cate H; de Fijter CW; Terpstra WE; Leyte A
Nephrol Dial Transplant; 2012 Apr; 27(4):1446-53. PubMed ID: 21873622
[TBL] [Abstract][Full Text] [Related]
19. Evolving role of microparticles in the pathophysiology of endothelial dysfunction.
Lovren F; Verma S
Clin Chem; 2013 Aug; 59(8):1166-74. PubMed ID: 23529703
[TBL] [Abstract][Full Text] [Related]
20. Membrane microparticles and diseases.
Wu ZH; Ji CL; Li H; Qiu GX; Gao CJ; Weng XS
Eur Rev Med Pharmacol Sci; 2013 Sep; 17(18):2420-7. PubMed ID: 24089218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
